2025-05-11 - Analysis Report
## Starbucks Corp (SBUX) Stock Report

**0. Key Figures & Initial Analysis:**

Starbucks Corp is a global coffeehouse chain operating in various countries.  The provided data reveals a significant underperformance of SBUX compared to the S&P 500 (VOO) over a certain period.  Further analysis is needed to understand the underlying reasons.

**1. Performance Comparison:**

* **SBUX Cumulative Return:** 17.46%
* **VOO (S&P 500) Cumulative Return:** 87.98%
* **Return Difference:** -70.5%  (SBUX underperformed VOO by 70.5%).
* **Relative Divergence:** 26.6% (This indicates that the current underperformance of SBUX relative to VOO is in the lower 26.6% percentile of historical divergences).

**Alpha and Beta Analysis:**

The provided Alpha and Beta values show a negative Alpha for the years 2015-2017 and 2016-2018, indicating underperformance relative to the market during those periods. Subsequently, positive Alpha values emerged (0.4 to 2.4), suggesting outperformance in the following years. However, this outperformance has been eroded in the more recent periods (2022-2025) resulting in negative CAGR.  The high Beta values (mostly above 50) indicate significant market sensitivity (higher risk).


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 1.0% | 58.4% | -32.0% | 54.7 |
| 2016-2018  | 3.0% | 59.1% | -18.0% | 62.7 |
| 2017-2019  | 55.0% | 59.1% | 21.0% | 87.2 |
| 2018-2020  | 63.0% | 61.7% | 33.0% | 108.4 |
| 2019-2021  | 53.0% | 61.7% | -7.0% | 120.4 |
| 2020-2022  | -27.0% | 66.9% | -36.0% | 104.6 |
| 2021-2023  | -29.0% | 68.1% | -50.0% | 103.3 |
| 2022-2024  | -32.0% | 68.1% | -52.0% | 100.8 |
| 2023-2025  | -11.0% | 68.1% | -38.0% | 91.2 |


**2. Recent Price Movement:**

* **Closing Price:** $82.19
* **Last Market Price:** $80.3 (a decrease of $1.89 or -2.3%)
* **5-Day Moving Average:** $82.81
* **20-Day Moving Average:** $82.96
* **60-Day Moving Average:** $95.94

The current price is below all three moving averages, suggesting a downward trend.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.37 (Medium Risk)
* **RSI:** 51.79 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.69 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** -1.2 (Short-term downward trend)
* **Expected Return:** -126.2% (This extremely negative value needs further clarification.  Is this a miscalculation or is it referencing a very specific scenario?)

The recent price drop of $2.3 reflects a short-term negative move.  The negative expected return warrants further investigation regarding its calculation and assumptions.

**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-04-29 | $0.34 | $8.76B      |
| 2025-01-28 | $0.69 | $9.40B      |
| 2024-07-30 | $0.93 | $9.11B      |
| 2024-04-30 | $0.68 | $8.56B      |
| 2024-04-29 | $0.68 | $8.56B      | *(Duplicate entry?)*


Earnings show some volatility.  There appears to be a duplicate entry for 2024-04-29 and 2025-04-29.  Further investigation is needed to clarify the data and analyze trends in EPS and revenue.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2025-03-31  | $8.76B   | 21.09%        |
| 2024-12-31  | $9.40B   | 24.49%        |
| 2024-09-30  | $9.07B   | 26.25%        |
| 2024-06-30  | $9.11B   | 27.91%        |
| 2024-03-31  | $8.56B   | 25.58%        |


Revenue shows some fluctuation, but generally remains relatively stable. Profit margins are consistently high, although there is a slight downward trend in recent quarters.

**Capital and Profitability:**

| Quarter     | Equity    | ROE      |
|-------------|-----------|----------|
| 2025-03-31  | -$7.62B   | -5.04%   |
| 2024-12-31  | -$7.47B   | -10.45%  |
| 2024-09-30  | -$7.45B   | -12.21%  |
| 2024-06-30  | -$7.95B   | -13.28%  |
| 2024-03-31  | -$8.45B   | -9.14%   |

Negative equity values and negative ROE are concerning and require further investigation into the company's financial health.  This indicates that the company may be using significant leverage.


**6. Overall Analysis:**

SBUX has significantly underperformed the S&P 500 over the measured period. While there were periods of strong outperformance (positive Alpha), recent performance has been weak (negative CAGR).  The negative equity and ROE figures raise serious concerns about the company's financial health.  The high Beta suggests substantial market risk.  Further analysis is needed to determine the underlying causes for the underperformance and the negative financial indicators.  The accuracy and context of the -126.2% expected return must be investigated.  Before making any investment decision, a thorough review of the company's financial statements and future prospects is crucial.  The data provided has inconsistencies that need to be resolved before making conclusive statements.
